150 related articles for article (PubMed ID: 30414597)
1. Underdosing of Surfactant for Preterm Babies with Respiratory Distress Syndrome in Clinical Practice: A Retrospective Cohort Study.
Boix H; Rite S; Arruza L; Fernandez C; Serrano I; Baquedano I; Sanchez A; Ferreira E; Fernandez P; Gonzalez R; Elorza MD
Am J Perinatol; 2019 Jul; 36(9):943-948. PubMed ID: 30414597
[TBL] [Abstract][Full Text] [Related]
2. Appropriateness of surfactant dosing for preterm babies with respiratory distress syndrome: retrospective cohort study.
Jourdain G; Zacaria F; Ammar F; De Luca D
Arch Dis Child Fetal Neonatal Ed; 2016 Mar; 101(2):F182-3. PubMed ID: 26785859
[No Abstract] [Full Text] [Related]
3. Surfactant Administration in Preterm Infants: Drug Development Opportunities.
Taylor G; Jackson W; Hornik CP; Koss A; Mantena S; Homsley K; Gattis B; Kudumu-Clavell M; Clark R; Smith PB; Laughon MM
J Pediatr; 2019 May; 208():163-168. PubMed ID: 30580975
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
Jeon GW; Oh M; Sin JB
Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
[TBL] [Abstract][Full Text] [Related]
5. Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome.
Jardine L; Lui K; Liley HG; Schindler T; Fink J; Asselin J; Durand D
Arch Dis Child Fetal Neonatal Ed; 2022 Jan; 107(1):51-55. PubMed ID: 34112722
[TBL] [Abstract][Full Text] [Related]
6. Effect of two different early rescue surfactant treatments on mortality in preterm infants with respiratory distress syndrome.
Kadıoğlu Şimşek G; Kanmaz Kutman HG; Canpolat FE; Oğuz ŞS
Clin Respir J; 2020 Mar; 14(3):285-290. PubMed ID: 31814293
[TBL] [Abstract][Full Text] [Related]
7. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
[TBL] [Abstract][Full Text] [Related]
8. The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study.
Lamboley-Gilmert G; Lacaze-Masmonteil T;
Paediatr Drugs; 2003; 5(9):639-45. PubMed ID: 12956620
[TBL] [Abstract][Full Text] [Related]
9. Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome.
Köksal N; Akpinar R; Cetinkaya M
Turk J Pediatr; 2009; 51(6):556-64. PubMed ID: 20196389
[TBL] [Abstract][Full Text] [Related]
10. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome.
Fujii AM; Patel SM; Allen R; Doros G; Guo CY; Testa S
J Perinatol; 2010 Oct; 30(10):665-70. PubMed ID: 20336076
[TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome.
Dizdar EA; Sari FN; Aydemir C; Oguz SS; Erdeve O; Uras N; Dilmen U
Am J Perinatol; 2012 Feb; 29(2):95-100. PubMed ID: 22105435
[TBL] [Abstract][Full Text] [Related]
12. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Osborn DA
Cochrane Database Syst Rev; 2012 Oct; 10():CD008310. PubMed ID: 23076945
[TBL] [Abstract][Full Text] [Related]
13. A shared protocol for porcine surfactant use in pediatric acute respiratory distress syndrome: a feasibility study.
Wolfler A; Piastra M; Amigoni A; Santuz P; Gitto E; Rossetti E; Tinelli C; Montani C; Savron F; Pizzi S; D'amato L; Mondardini MC; Conti G; De Silvestri A
BMC Pediatr; 2019 Jun; 19(1):203. PubMed ID: 31215483
[TBL] [Abstract][Full Text] [Related]
14. Impact of Minimally Invasive Surfactant Therapy in Preterm Infants at 29-32 Weeks Gestation.
Dargaville PA; Ali SKM; Jackson HD; Williams C; De Paoli AG
Neonatology; 2018; 113(1):7-14. PubMed ID: 28922658
[TBL] [Abstract][Full Text] [Related]
15. Neurodevelopmental outcomes of very low birth weight preterm infants treated with poractant alfa versus beractant for respiratory distress syndrome.
Eras Z; Dizdar EA; Kanmaz G; Guzoglu N; Aksoy HT; Altunkaya GB; Canpolat FE; Dilmen U
Am J Perinatol; 2014 Jun; 31(6):463-8. PubMed ID: 23884719
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial.
Vento G; Pastorino R; Boni L; Cota F; Carnielli V; Cools F; Dani C; Mosca F; Pillow J; Polglase G; Tagliabue P; van Kaam AH; Ventura ML; Tana M; Tirone C; Aurilia C; Lio A; Ricci C; Gambacorta A; Consigli C; D'Onofrio D; Gizzi C; Massenzi L; Cardilli V; Casati A; Bottino R; Pontiggia F; Ciarmoli E; Martinelli S; Ilardi L; Colnaghi M; Matassa PG; Vendettuoli V; Villani P; Fusco F; Gazzolo D; Ricotti A; Ferrero F; Stasi I; Magaldi R; Maffei G; Presta G; Perniola R; Messina F; Montesano G; Poggi C; Giordano L; Roma E; Grassia C; Ausanio G; Sandri F; Mescoli G; Giura F; Garani G; Solinas A; Lucente M; Nigro G; Del Vecchio A; Petrillo F; Orfeo L; Grappone L; Quartulli L; Scorrano A; Messner H; Staffler A; Gargano G; Balestri E; Nobile S; Cacace C; Meli V; Dallaglio S; Pasqua B; Mattia L; Gitto E; Vitaliti M; Re MP; Vedovato S; Grison A; Berardi A; Torcetta F; Guidotti I; di Fabio S; Maranella E; Mondello I; Visentin S; Tormena F
Trials; 2016 Aug; 17():414. PubMed ID: 27538798
[TBL] [Abstract][Full Text] [Related]
17. [A multicenter study on the surfactant treatment in late-preterm or term infants with respiratory distress syndrome].
Collaborative Study Group for Late-preterm/Term Infants with Respiratory Distress
Zhonghua Er Ke Za Zhi; 2014 Oct; 52(10):724-8. PubMed ID: 25537535
[TBL] [Abstract][Full Text] [Related]
18. Early rescue administration of surfactant and nasal continuous positive airway pressure in preterm infants <32 weeks gestation.
Tsakalidis C; Kourti M; Karagianni P; Rallis D; Porpodi M; Nikolaidis N
Indian Pediatr; 2011 Aug; 48(8):601-5. PubMed ID: 21169644
[TBL] [Abstract][Full Text] [Related]
19. Nasal intermittent positive pressure ventilation with or without very early surfactant therapy for the primary treatment of respiratory distress syndrome.
Duman N; Tüzün F; Sever AH; Arslan MK; İşcan B; Dilek M; Kumral A; Ozkan H
J Matern Fetal Neonatal Med; 2016; 29(2):252-7. PubMed ID: 25491882
[TBL] [Abstract][Full Text] [Related]
20. Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?
Tsakalidis C; Giougki E; Karagianni P; Dokos C; Rallis D; Nikolaidis N
Turk J Pediatr; 2012; 54(4):368-75. PubMed ID: 23692717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
